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NanoparticleAlphaviruses are comprised of a nucleocapsid core surrounded by a lipid membrane containing glycoprotein
spikes. Previous work demonstrated that in vitro assembled core-like particles are similar in structure to the
nucleocapsid core in the native virus. Here we demonstrate that in vitro assembled core-like particles can be
inserted into viral glycoprotein-expressing cells to generate enveloped virus-like particles. These virus-like
particles bud from cells like native virus, are similar in size to the native virus, and can enter cells to release the
contents of the core-like particle into the cytoplasm of the cell. Virus-like particles can be used to infect cells
with biological and non-biological cargoes. The generation of enveloped virus-like particles containing an in
vitro core and in vivo synthesized glycoproteins has applications for gene and drug delivery, medical imaging,
and also basic mechanistic studies of virus assembly., sumukhop@indiana.edu
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Alphaviruses are simple, enveloped viruses with a positive-sense
RNA genome (Strauss and Strauss, 1994). The particle is ~70 nm in
diameter and has three concentric layers: a central nucleocapsid core
that consists of the viral genome surrounded by the capsid protein, a
host-derived lipid membrane that covers the core, and, on the surface
of the particle, 80 trimeric glycoprotein spikes that are embedded in
the lipid membrane (Cheng et al., 1995; Mukhopadhyay et al., 2006).
Alphavirus particle assembly consists of two parallel and inde-
pendent pathways, nucleocapsid core and glycoprotein spike forma-
tion. The two pathways merge during budding, the ﬁnal stage of virus
assembly. The ﬁve structural proteins, capsid–E3–E2–6K–E1, are
synthesized from a 26s subgenomic mRNA. The capsid protein is
autoproteolytically cleaved from the polyprotein during translation
(Melancon and Garoff, 1987). In the cytoplasm, 240 capsid proteins
and one progeny genome self-assemble to form a nucleocapsid core.
The remainder of the polyprotein, E3–E2–6K–E1, is co-translationally
translocated into the ER where it is cleaved into individual proteins.
Spikes are assembled in the ER and Golgi, and transported to the
plasma membrane via the host cell secretory machinery (Wahlberg
et al., 1989; Ziemiecki et al., 1980). During budding, the nucleocapsid
core protrudes through the cell membrane embedded with glycopro-
tein spikes and a virus particle is released from the cell. It is
hypothesized that the interaction between the cytoplasmic tail of the
E2 protein and the hydrophobic pocket in the capsid protein aids in
assembly and stabilizes the virus particle (Lee et al., 1996; Skoging
et al., 1996;Wilkinson et al., 2005; Zhao et al., 1994). Mutations in theE2 cytoplasmic tail inhibited virus budding and reduced particle
formation (Owen and Kuhn, 1997; West and Brown, 2006). While the
amino acid sequence of E2 cytoplasmic tails is similar (Lee et al., 1996;
Skoging et al., 1996), chimeric viruses where the glycoproteins are
from one alphavirus species and the capsid is from another species,
form very low levels of particles compared to the parental viruses
(Lopez et al., 1994). Non-enveloped nucleocapsid cores are not
released from cells. The distinct and separable assembly pathways
make alphaviruses an attractive system for synthesizing enveloped
virus-like particles (VLPs) using in vitro assembled components.
Alphavirus core-like particles (CLPs) have been assembled in vitro
by mixing recombinant alphavirus capsid protein and single-stranded
nucleic acid (Tellinghuisen et al., 1999). CLPs can also be assembled
using artiﬁcial scaffolds such as nanoparticles (Goicochea et al., 2007)
and polyanions such as heparin (F. Cheng and S. Mukhopadhyay,
unpublished data). Cryo-electron microscopy and 3D image recon-
structions of CLPs containing a DNA oligomer demonstrated that the
CLPs are approximately 40 nm in diameter and that the capsid protein
subunits within the CLPs are arranged with T=4 icosahedral
symmetry (Mukhopadhyay et al., 2002): both are characteristics of
wild-type nucleocapsid cores. However, previous studies of CLPs did
not demonstrate whether or not they could interact with glycoprotein
spikes to form VLPs.
In this study, we show that in vitro assembled alphavirus CLPs can
associatewith alphavirusglycoproteins to formenvelopedVLPs. Thus, in
vitro assembled CLPs retain the functionality of nucleocapsid core in the
absence of any host chaperones. As with native alphaviruses, these in
vitro assembled VLPs enter cells via the endocytotic pathway.
Furthermore, the VLPs can disassemble and release the contents within
the encapsidated CLP. This is the ﬁrst demonstration that a functional
enveloped virus-like particle containing an in vitro assembled core can
be synthesized. The ability to make VLPs containing different cargoes in
154 F. Cheng, S. Mukhopadhyay / Virology 413 (2011) 153–160their CLP has signiﬁcance for basicmechanistic studies of virus assembly
as well as drug and nucleic acid delivery and medical imaging
applications.
Results and discussion
In vitro core-like particles are assembled using different cargoes
Capsid proteins from Sindbis,Western equine encephalitis, and Ross
River virus expressed in E. coli have been shown to assemble into CLPs
under similar assembly conditions (Mukhopadhyay et al., 2002;
Tellinghuisen et al., 1999).We used the Ross River virus systembecause
full-length capsid protein can be obtained in high yields from a
recombinant bacterial expression system, resulting in the reproducible
synthesis of higher concentrations of CLPs (Mukhopadhyay et al., 2002).
Furthermore, CLPs can be packaged with a variety of polyanions and
both RNA- and DNA-containing CLPs were used in this work. Puriﬁed
CLPs were homogeneous and approximately 40 nm in diameter like
cytoplasmic cores from virus-infected cells and the nucleocapsid core
from virus particles (Figs. 1a–c). Yields of puriﬁed CLPs were 30–50% of
the starting capsid protein in numerous independent preparations.
Functional alphavirus glycoproteins are synthesized in BHK cells
To create a cell line that transiently expressed surface glycopro-
teins for enveloping in vitro assembled CLPs, we cloned the gene
fragment encoding the wild-type Ross River virus E3–E2–6K–E1
proteins into the pCAGGS DNA vector (pRRV-GP) for transientFig. 1. Puriﬁed core-like particles and cytoplasmic cores. Puriﬁed core-like particles containin
RNA are shown in negative stain TEM images. Puriﬁed cytoplasmic cores isolated from BH
cytoplasmic nucleocapsid cores (c) are 40 nm in diameter and are homogeneous, spherical pa
transfected cells. Cells were transfected with pRRV-GP, pRRV-mtGP, or pSV-GP for 15 h and
GP and pRRV-mtGP) or Sindbis E2 (pSV-GP) antibody. Untreated cells (Mock) and virus-in
controls, respectively. All panels were stained with TRITC-conjugated goat anti-rabbit second
Cells were imaged at 20× magniﬁcation on an Olympus 1X71 ﬂuorescence microscope.expression, guided by expression systems previously described
(Kondor-Koch et al., 1983; Liljestrom and Garoff, 1991). As a negative
control, pRRV-GP was modiﬁed (pRRV-mtGP) so amino acid residues
399–401 of the E2 cytoplasmic tail were mutated from YAL to DDD.
The glycoproteins synthesized from pRRV-mtGP should not interact
with CLPs because the putative hydrophobic interaction between the
E2 cytoplasmic tail and the capsid protein has been disrupted (Owen
and Kuhn, 1997; West et al., 2006; Zhao et al., 1994). As a second
negative control, we cloned the glycoproteins from wild-type Sindbis
virus (pSV-GP) into the pCAGGS vector to investigate the speciﬁcity of
RRV CLPs towards other alphavirus glycoproteins.
BHK cells transfected with either pRRV-GP, pRRV-mtGP, or pSV-GP
produced comparable amounts of the E2 protein and its precursor, pE2
(also called p62), as determined by western blot analysis (data not
shown). The cellular distribution of glycoproteins frompRRV-GP, pRRV-
mtGP, and pSV-GP was similar to each other and to virus-infected cells
(Fig. 1d). Cells transfected with pRRV-GP, pRRV-mtGP, and pSV-GP
could undergo cell-to-cell fusion under low pH conditions (Chanel-Vos
and Kielian, 2004; Hernandez et al., 2003) suggesting the expressed
glycoproteins canmediatemembrane fusion,whereasmock transfected
cells did not form syncytia at any pH tested. These results are consistent
with those reported for other alphavirus systems.
Cytoplasmic cores form virus particles with viral glycoproteins produced
from pRRV-GP
In virus-infected cells, cytoplasmic nucleocapsid cores contain the
viral genome. Initially we investigated whether or not we could formg recombinant Ross River capsid protein and (a) 48mer DNA oligomer and (b) luciferase
K infected with Ross River virus are shown in (c). Core-like particles (a and b) and
rticles. (d) Expression of viral glycoproteins from pRRV-GP-, pRRV-mtGP-, and pSV-GP-
then ﬁxed with 1.5% paraformaldehyde in PBS before being treated with RRV E2 (pRRV-
fected cells (RRV infection and Sindbis infection) were used as negative and positive
ary except RRV infection which was treated with FITC-conjugated secondary antibody.
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expressing viral glycoproteins from pRRV-GP. This approach used
assembly components most similar to those found in a virus infection.
We transfected 18 μg, or 1.6×1012 puriﬁed cytoplasmic nucleocap-
sid cores from Ross River virus-infected cells into 1.4×107 BHK cells
previously transfected with pRRV-GP or into 1.4×107 non-transfected
BHK control cells. After 1 h cells were washed and after an additional
hour incubated in freshmedium, the latterwas collectedand assayed for
infectious particles. The short incubation time minimized the chance of
genome replication and virus assembly from a disassembled cytoplas-
mic core. There were 300–600 pfu (~102 pfu/ml) from pRRV-GP-
transfected cells. In contrast, no infectious particles were isolated from
BHK control cells. This indicates that cytoplasmic cores by themselves
did not disassemble and could not propagate infections in our time
frame. The low titer of the infectious virus likely reﬂects a combination
of low transfection efﬁciency of cytoplasmic cores, the limited transport
of cytoplasmic cores to the appropriate membrane for packaging, and
the short time period over which we collected particles. Nevertheless,
these results show that cells transfected with cytoplasmic cores can
generate infectious virus particles.
Optimizing the strategy for generating VLPs
We sought to determinewhether in vitro assembled Ross River CLPs
could associate with Ross River glycoproteins expressed in trans to form
VLPs.Weﬁrst needed todetermine the timingof the transfection of CLPs
into BHK cells and timing of particle budding. Transfection is highly
dependent on the size of the entering particle and its surface charge.
Although transfection has been successfully used with cores of other
viral systems (Bichko et al., 1994; Jiang and Coombs, 2005), it has not
been previously reported for alphavirus nucleocapsid cores. We
determined CLP transfection by monitoring the presence of capsid
protein in newly transfected cells. We transfected 3 μg CLPs containing
48mer DNA (~2.6×1011 CLPs) into 2.4×106 non-transfected BHK
control cells using Lipofectamine 2000 as usedwith other virus systems.
At various times post-transfection, the cells werewashed and lysed, and
the lysates were then probed for capsid protein by western blotting
(Fig. 2a). The capsid protein in these cells would be from the CLPs thatFig. 2. Timing of virus-like particle production. (a) Time course for core-like particle
transfection. BHK cells (2.4×106) were transfected with CLPs containing 48mer DNA
oligomer (3 μg, 2.6×1011 particles) and after the indicated time, cells were washed to
remove non-transfected CLPs, and then lysed. Cell lysates were run on a SDS-PAGE and
probed for capsid protein. Each data point represents a separate transfection. (b) Time
course for release of VLPs. BHK cells transfected with pRRV-GP (1.4×107 cells) were
transfected with CLPs containing 48mer DNA oligomer (19 μg, 1.6×1012 particles).
After 1 h, cells were washed and new medium was added. After one additional hour,
medium was collected (9 ml) at different times, centrifuged, and the pellet probed for
capsid protein. Zero time is deﬁned as immediately after washing cells and adding fresh
media. At 30 min the medium contains VLPs released between 0 and 30 min. Similarly
60 min and 120 min correspond to collecting VLPs released between 30 and 60 min and
60 and 120 min after adding medium, respectively. The absence of capsid protein at
zero time indicates that the washing step removed all non-transfected CLPs. Far left
lane is a positive control of puriﬁed capsid protein.were transfected into them. Thepresence of capsid proteinwasdetected
within 15 min post-transfection and reached amaximum at 30–60 min
post-transfection. Levels of capsid protein started to decrease only after
4 h. The stability of the capsid protein suggests that CLPs are not
immediately disassembling because during a native alphavirus infec-
tion, the nucleocapsid core disassembles under acidic conditionswithin
2 min of entry into the cytoplasm (Wengler, 2009; Wengler and
Wengler, 2002). However, in these transfection assays, CLPs enter the
cytoplasmdirectly and bypass the endosome (Jiang and Coombs, 2005).
We hypothesized that the timing of virus-like particle budding
would be different than during a native alphavirus infection because
during production of VLPs, the corewas already assembled and ready to
bud. To determine the timing of potential VLPs being released into the
media, we assayed themedium for the presence of capsid protein as an
indicator of VLPs. We transfected 19 μg CLPs containing 48mer DNA
(~1.6×1012 CLPs) into 1.4×107 BHK cells expressing pRRV-GP. One
hour post-CLP transfection, cells were washed and fresh medium was
added; this is deﬁned as zero time.Medium from the cells was collected
at 30, 60, and 120 min and centrifuged. Thus, medium collected at
30 min contains particles released between 0 and 30 min, medium
collected at 60 min contains particles released between 30 and 60 min,
and medium collected at 120 min contains particles released between
60 and 120 min. After centrifugation, each sample was analyzed for the
presence of capsid protein (Fig. 2b). At t=0 no capsid protein was
detected indicating that non-transfected CLPs were completely re-
movedduring thewash step: all capsidprotein detected subsequently is
therefore from released VLPs. We could detect capsid protein in the
pelleted particles at 30 min but between 30 and 60min (time 60 min),
much less capsid proteinwas detected. These results indicate that virus-
like particle assembly and release was complete within 30 min of
addition of the fresh medium. One explanation for this narrow time
range for VLP production is that there is a ﬁnite number of CLPs inside
the viral glycoprotein-expressing cell. Once all the CLPs form into VLPs,
no more particles can be formed. In contrast, during a viral infection
cytoplasmic cores are continuously being synthesized so virus particles
are continuously being released from over a long period of time.
In a viral infection, genome replication and structural protein
synthesis occur before particle release. Particles are ﬁrst detected 4 to
6 h post-infection and continue to be released until 12 to 15 h post-
infection. In our assays, VLPs are produced much earlier than virus
particles are produced during an infection. When we transfect CLPs,
we are presumably initiating assembly at the last steps of budding
when the nucleocapsid cores interact with the glycoproteins andwere
able to form virus particles more quickly. The amount of VLPs released
depends upon the amount of CLPs that have been transfected since
new CLPs are not being synthesized within the cell.
Taking into account the above observations, we standardized our
protocol for making VLPs. Transfect BHK cells with pRRV-GP and, 15 h
laterwhen glycoprotein synthesiswas occurring, transfect puriﬁed CLPs
into the same cells. After 1 h, the medium was removed, cells were
washed with PBS to remove non-transfected CLPs, and fresh medium
was added. After an additional one hour incubation the medium was
collected and analyzed for VLPs. This timing was used for two reasons.
First, optimal yield of VLPswas obtained one hour post-CLP transfection
(as determined bywestern blot). Second, if we collected all themedium
post-CLP transfection and did not wash the cells, non-transfected CLPs
remaining in the medium would interfere with quantitation and
characterization of the VLPs. As a consequence of the timing of our
assays, wemay be underestimating the amount of VLPs that are formed.
Hypothetically, if CLPs enter the cell within 30 min and can bud and be
releasedwithin 15 min, these VLPswould not be collected in our assays.
VLPs contain viral glycoproteins and capsid protein
Our small scale optimization results, obtained by transfecting CLPs
into BHK cells expressing pRRV-GP, demonstrated that VLPs were
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glycoproteins were also present in the VLPs. We transfected 90 μg
CLPs containing 48mer DNA (~7.8×1012 CLPs) into 7.2×107 BHK cells
expressing pRRV-GP and into 7.2×107 non-transfected BHK control
cells. The medium from each sample (after the appropriate washes)
was applied to a sucrose cushion and centrifuged. The pellets from
pRRV-GP plus CLPs transfection contained both E2 and capsid protein
as determined by western blot (Fig. 3a, lane 4). In contrast,
resuspended pellets from CLPs transfected into control BHK cells
contained neither E2 nor capsid protein (Fig. 3a, lane 3). This result is
consistent with our hypothesis that VLPs only form in the presence of
CLPs and viral glycoproteins. In addition, it also demonstrated that
non-transfected CLPs were removed during the wash step. As a
positive control, Ross River virus was pelleted and 1.5×108 particles
were loaded on the gel (Fig. 3a, lane 2).
Virus-like particle formation requires E2-capsid interaction
The interaction between the cytoplasmic tail of the E2 protein and
the hydrophobic pocket of the capsid protein promotes virus budding.
We abolished this interaction when expressing an E2 mutant (pRRV-
mtGP) in which residues in the cytoplasmic tail were mutated from
YAL to DDD. Glycoprotein expression and syncytia formation for
pRRV-mGP were comparable to cells expressing pRRV-GP and virus-
infected cells (Fig. 1d). However when 108 μg of CLPs containing
48mer DNA oligomer (~9.3×1012 CLPs) was transfected into 7.2×107
BHK cells expressing pRRV-mtGP, neither E2 nor capsid protein was
detected in the resuspended pellet (Fig. 3b). If any VLPs formed with
the mutant glycoprotein pRRV-mtGP, their amounts were severelyFig. 3. Viral protein components of VLPs. (a) Western blot analysis of pelleted VLPs. The
medium containing VLPs (made from 90 μg CLPs containing 48mer DNA oligomer
transfected into pRRV-GP-transfected cells) was centrifuged. Pellets were resuspended
in ~50 μl PBS to yield 0.15 mg/ml of VLPs. Ten microliters of pelleted VLPs was probed
for E2 and capsid protein. Native Ross River virus was used as a control (lane 2).
(b) VLPs production reduced with pRRV-mtGP. BHK cells were transfected with pRRV-
mtGP and 108 μg CLPs containing 48mer DNA oligomer. Medium was collected,
centrifuged, and the pellet probed for E2 and capsid protein. Native Ross River virus was
pelleted as a control. Lane 1 contains 1×108 Ross River virus particles.reduced in comparison to those formed using pRRV-GP. When the
YAL-NDDD mutation was made in Ross River virus, no infectious
particles were detected in plaque assays. Thus, VLPs contain E2 and
capsid protein, and show an E2-capsid protein-dependent interaction.
VLPs are morphologically similar to native virus particles
Wewanted todetermine if themorphology and sizeof theVLPswere
similar to the native alphavirus particles.When viewed by transmission
electron microscope (TEM), the resuspended pellet from the pRRV-GP
plus CLPs transfected cells show spherical particles with a diameter of
approximately 70 nm by electron microscopy (Fig. 4a), consistent with
native alphavirus particles. The number of VLP observedwas fewer than
from a native infection. However, the distribution of particle size and
variation in particle shape were similar to what is observed when we
pelleted native virus. Some particles look less spherical in both the VLP
andnative viruspopulation andwe speculate that this is due to pelleting
virus particles. No unenveloped CLPs (40 nm diameter, spherical
particles) were observed. No spherical particles with either 70 or
40 nm diameter were found in the resuspended pellet from the control
experiment where CLPs transfected into non-viral glycoprotein expres-
sing cells. The absence of both virus-like and core-like particles in this
control was consistent with a western blot of the media (Fig. 3a).
Cryo EM structures of both in vitro assembled CLPs (Mukhopadhyay
et al., 2002) and isolated cytoplasmic nucleocapsid cores (Lamb et al.,
2010) indicate that these complexes are ﬂexible and undergo
glycoprotein-mediated conformation changes. From negative stain
TEM images, it was difﬁcult to determine if the glycoprotein spikes
were fully covering the CLP. To determine if therewere areas on the VLP
that were not surrounded by the spikes, thus the capsid proteins were
exposed, we assayed resuspended VLP pellets with anti-capsid protein
antibody. The rationalewas if the glycoprotein spikeswere not covering
theCLP then theVLPwouldbe immunoprecipitatedusing ananti-capsid
antibody. However, if the CLP was covered by glycoprotein spikes, as is
observed in native virus particles, then the VLPs would not bind to the
capsid antibody. Here, 20 μg of CLPs containing 48mer DNA (~1.7×1012
CLPs) was transfected into 1.4×107 BHK cells, both those expressing
RRV-GP and control cells not expressing viral glycoproteins. Concen-
trated VLPs were immunoprecipitated with anti-capsid antibody and
then analyzed by western blotting. No VLPs could be detected in the
medium from RRV-GP plus CLPs transfected cells indicating large areas
of capsid protein in the CLP was not surface exposed (Fig. 4b, lane 3). A
strong capsid protein bandwas detected when we directly added 15 μg
(~1.2×1012 particles) CLPs to the medium, pelleted the CLPs, and
immunoprecipitated the resuspended pellet with anti-capsid antibody
(Fig. 4b, lane 6). The absence of detectable capsid protein in medium
from CLPs transfected into control BHK cells (Fig. 4b, lane 2)
demonstrated that secretion of VLPs requires glycoproteins, consistent
with native alphavirus particles.
VLPs can enter and disassemble in cells
We tested the entry and disassembly activity of our VLPs by creating
particles that contain luciferase RNA reporter. We synthesized VLPs
from CLPs containing luciferase RNA, 18 μg CLPs transfected into
1.4×107 BHK cells transfected with RRV-GP or into non-transfected
BHK control cells. Medium containing the VLPs (total volume=3ml)
was incubated with 2.4×106 BHK cells. After 12 h, cells were lysed and
assayed for luciferase activity. This incubation is intended to mimic an
infection; no transfection reagent was included. Luciferase would only
be translated if the VLPs could enter and disassemble within the new
cell. Within each set of experiments, the luciferase activity detected
from BHK cells that were incubated with medium from pRRV-GP plus
CLP-transfected cells was set to 1 (Fig. 5a). Cells that were incubated
with medium from CLPs transfected into BHK control cells had
background levels of luminescence (Fig. 5a).
Fig. 4.Morphology of VLPs. (a) TEM images of VLPs. Concentrated VLPs were stained with uranyl acetate and visualized by TEM. A sample of Ross River virus prepared the same way
is also shown. (b) VLPs are covered by viral glycoproteins. Immunoprecipitation experiments were performed on concentrated VLPs using anti-capsid antibody. Twenty microliters
of resuspended pelleted VLPs (~3 μg) was added to beads alone (− antibody) or beads coupled with capsid protein antibody (+ antibody). No capsid protein was detected (lane 3,
pRRV-GP+CLPs). No capsid protein was detected in pellets from medium of CLPs transfected into control BHK cells (lane 2, BHK+CLPs). The positive control of CLPs containing
48mer DNA (18 μg, ~1.6×1012 CLPs) added to the medium of BHK cells showed a strong band corresponding to capsid protein in lane 6 (Media+CLPs), demonstrating that CLPs can
be detected in growth medium. Puriﬁed capsid protein is shown in lane 1 as a control.
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receptor-mediated endocytosis (Bron et al., 1993; Marsh et al., 1984).
Entry at neutral pH at the plasma membrane has also been reported
(Paredes et al., 2004). We speciﬁcally tested the hypothesis that VLPs
entered BHK cells using the same route as Ross River virus. We
blocked the entry using a neutralizing antibody and inhibiting pH
change in the endosome.
The epitope of the Ross River neutralizing antibody T10C9 is the
receptor-binding domain of the E2 protein (Smith et al., 1995; Vrati
et al., 1988). When 3 ml of medium containing VLPs made with
luciferase CLPs was incubated with 500 μl of T10C9 antibody in serum,
the luciferase activity in the incubated BHK cells was reduced by 50%
compared to VLPs not treated with the neutralizing antibody. These
results demonstrate that an E2-speciﬁc neutralizing antibody is able to
interfere with virus-like particle entry into host cells, consistent with
what is observed with native Ross River virus (Vrati et al., 1988)
(Fig. 5b).
When BHK cellswere pre-treatedwithNH4Cl and then infectedwith
Ross River virus, we observed a decrease in titer from 108 to 105 pfu/ml
(Fig. 5b) as previously reported for other alphaviruses (Glomb-
Reinmund and Kielian, 1998; Helenius et al., 1982). Similarly, VLPs
showed reduced luminescence in BHK cells that had been pre-treated
with NH4Cl; the luciferase activity was reduced by 70% suggesting that
VLP entry occurs via the endosomal pathway, where either fusion and/
or core disassembly may be affected by the change in pH of the NH4Cl-
incubated cell.
When blocking entry of the VLPs, the luciferase activity of the cells is
decreased compared to untreated VLPs but still remains higher than the
backgroundCLP luminescencevalue (Fig. 5a, CLP). Possible explanations
could include that some VLPs do not enter cells via the receptor-mediated endosomal pathway or the arrangement of the spikes around
the particle does not allow for complete neutralization by the T10C9
antibody. In Ross River virus treatedwith antibody andpre-treatment of
cells with NH4Cl, there was only a partial decrease in viral titer which
correlates with our luciferase assay results (Fig. 5b). An alternative
explanation for the luciferase activities not return to background levels
is the CLP may be enveloped by any viral glycoprotein-containing
membrane and, as a result, particles may show increased luminescence
in cells. To test this hypothesis, we transfected 3.6 μg (~3.1×1011 CLPs)
made with Ross River capsid protein into 2.4×106 BHK cells expressing
Sindbis virus glycoproteins, pSV-GP. After the appropriate washes,
medium was collected and added to 2.4×106 BHK cells. Here, the
luminescence of cells treated with medium from the RRV CLP+SV-GP
VLPs was equal to background levels. Previous reports have demon-
strated that chimera viruses where the Ross River capsid protein was
exchanged with a Sindbis capsid protein in a Ross River background, or
the Sindbis capsid protein was exchanged with a Ross River capsid
protein in a Sindbis background (Lopez et al., 1994), grew very poorly or
~103 pfu/ml (Fig. 5b). Our low levels of luciferase activity are consistent
with these results and suggest that VLPs are not being formed when
Ross River CLPs are transfected into pSV-GP cells.
Concluding remarks
Animal viruses have natural and efﬁcient entry mechanisms
making them ideal vector systems for real-time imaging and drug
delivery. However, potential dangerous effects due to the presence of
the parental virus genome are concerns. In the alphavirus based VLPs,
the cell entry properties associated with the glycoprotein spikes are
retained but the genome and its pathogenic effects are eliminated
Fig. 5. Biological activity of VLPs and infectivity of virus. (a) Biological activity of VLPs.
VLPs containing Ross River capsid protein and luciferase RNA were made and 3 ml of
the preparation was incubated with BHK cells (2.4×105) for 1 h. After 12 h, the cells
were lysed and assayed for luciferase activity. Within each set of experiments,
luminescence values from cells incubated with medium from cells transfected with
pRRV-GP and CLPs were normalized to 1 (VLP) since the minimum and maximum
luminescence varied between experiments. Cells were incubated with medium from
BHK cells transfected with CLPs only (CLP). VLPs were incubated with the Ross River
neutralizing antibody, T10C9, for 30 min at room temperature before being added to
BHK cells (VLP+antibody). BHK cells were pre-treated with NH4Cl before addition of
VLPs (VLP+NH4Cl). VLPs from CLPs containing luciferase RNA were transfected into
BHK expressing pSV-GPwere collected and used to infect BHK cells (RRVCLP+pSV-GP).
(b) Ross River virus infectivity. Infectivity of Ross River virus alone (WT RRV), in the
presence of T10C9 neutralizing antibody (RRV+antibody), and after being ampliﬁed in
the presence of ammonium chloride (RRV+NH4Cl). The titer from the chimera virus,
SIN(RRc), which contains Ross River capsid protein in a Sindbis background is taken
directly from Lopez et al. The virus “CP” is a replicon derivative that contains only the
non-structural proteins and the capsid protein. The average of two experiments for
CP, RRV+antibody, and RRV+NH4Cl is shown. Panels (a) and (b) are only to show
trends in the data and cannot be directly compared.
158 F. Cheng, S. Mukhopadhyay / Virology 413 (2011) 153–160because the cargo within the CLP is not speciﬁc to the viral genome.
We have demonstrated that VLPs can enter and disassemble within a
new host cell and there is a strong correlation between the biological
activity of VLPs as determined by luciferase activity and virus
infectivity as determined by plaque assay.
We can expand our work with Ross River VLPs to generate other
alphavirusVLPs, extending speciﬁcity andcell targeting.Many alphavirus
capsid proteins form CLPs using nucleic acid (Hong et al., 2006;
Mukhopadhyay et al., 2002; Tellinghuisen andKuhn, 2000; Tellinghuisen
et al., 1999, 2001). In addition, CLP formation using inorganic cargoes
towards medical imaging has also been demonstrated (Goicochea et al.,
2007). It has been demonstrated in mice that Sindbis viral vectors
speciﬁcally infect tumors because the virus particles bind to over-
expressed laminin receptor synthesized inmany tumors (Scheimanet al.,
2010; Tseng et al., 2004), suggesting oncolytic potential for this system
(Scheiman et al., 2010; Tseng et al., 2004).The enveloped VLP system provides a means to deliver toxic and
labile cargoes. Toxic cargoes will only be released once the VLPs enter
the target cell. Similarly, labile cargoes are protecteduntil they are inside
the target cell. Applications using VLPs include intracellular delivery of
small molecule drugs, siRNAs of modulation of gene expression, and
nanoparticles for imaging. The VLP system will require further
optimization for maximum production of VLPs and thatmay be speciﬁc
to the cargo of the CLP. Our results demonstrate the ﬁrst steps in the use
of alphavirus nanoparticles in basicmechanistic virology studies aswell
as in application-driven uses of the VLPs.
Materials and methods
Viruses and cells
The T48 strain of Ross River virus (Kuhn et al., 1991) was used in this
work. BHK-21 cells (American Type Tissue Culture, Rockville, MD) were
grown in minimal essential medium (MEM, Invitrogen, Carlsbad, CA)
supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals,
Lawrenceville, GA), non-essential aminoacids, glutamine, andpenicillin/
streptomycin. Cells were grown at 37 °C in the presence of 5% CO2. The
neutralizing Ross River antibody, T10C9, was generously provided by
Richard Kuhn, Purdue University.
Transient expression of alphavirus glycoproteins
The viral glycoproteins E3–E2–6K–E1 from Ross River virus were
cloned into a pCAGGS vector; pRRV-GP. A mutant of RRV-GP where
amino acid residues E2-399–401 are mutated from YAL to DDD was
created by Quick Change mutagenesis (Stratagene, La Jolla, CA);
pRRV-mtGP. The viral glycoproteins E3–E2–6K–E1 from Sindbis virus
were cloned into a pCAGGS vector; pSV-GP. BHK cells were
transfected with pRRV-GP/pRRV-mtGP/pSV-GP using Lipofectamine
2000 (Invitrogen), following the manufacturer's instructions. Viral
glycoprotein expression was determined by western blotting of cell
lysates and immunoﬂuorescence assays using a polyclonal Ross River
E2 or Sindbis E2 antibody (Cocalico, Reamstown, PA), and FITC- or
TRITC-conjugated goat anti-rabbit secondary antibody.
Syncytia assays
Syncytia assays were performed to determine if cells expressing
pRRV-GP, pRRV-mtGP, and pSV-GP were able to mediate fusion. BHK
cells were transfected with pRRV-GP, pRRV-mtGP, or pSV-GP using
Lipofectamine 2000 (Invitrogen). After 15 h, cells were treated with
200 μl MEM with 20 mM HEPES or 20 mM MES at the speciﬁed pH
(ranging frompH7.5 to5) for 3 min at 37 °C. Themediumwas removed,
MEM plus 10% FBS was added, and the cells were incubated for an
additional 1 h at 37 °C. Syncytia were clearly visible under bright ﬁeld.
Isolation of cytoplasmic cores from virus-infected cells
Cytoplasmic cores were isolated as described previously (Lopez
et al., 1994). Brieﬂy, BHK cells were infected at MOI=5with Ross River
virus and 18 h post-infection cytoplasmic cores were harvested in
10 mM Tris (pH 7.5), 10 mM NaCl, and 20 mM EDTA. Lysed cells were
incubated on ice for 20 min and then Triton X-100 was added to a ﬁnal
concentration of 3%. Cells were vortexed gently and then centrifuged at
4000×g for 10 min at 4 °C. Lysates were loaded on a 0–50% sucrose
gradient prepared in 20 mM HEPES, 150 mM NaCl, 0.1 mM EDTA, and
0.1%TX-100 and centrifuged in a SW41 rotor at 178,000×g for 90 min at
12 °C (Lopez et al., 1994). The fraction containing the nucleocapsid cores
was concentrated and buffer-exchanged into PBS. Bradford assays were
used to determine the concentration of the cytoplasmic cores.
159F. Cheng, S. Mukhopadhyay / Virology 413 (2011) 153–160In vitro assembly of core-like particles
Ross River capsid protein was cloned into a pET 29b vector
(Novagen, EMD Chemical Inc., Gibbstown, NJ) and expressed in
Rosetta 2 cells (Novagen, EMD Chemical Inc.). Capsid protein
puriﬁcation was performed as described previously (Mukhopadhyay
et al., 2002; Tellinghuisen et al., 1999). Ross River capsid protein was
concentrated and buffer exchanged into 20 mMHEPES, 150 mMNaCl,
and 0.1 mM EDTA for use in CLP reactions. For composition and
morphology studies, the nucleic acid cargo was a 48mer DNA
oligomer (5′-CCGTTAATGCATGTCGAGATATAAAGCATAAGGGACATGC
ATTAACGG-3′) (IDT, Coralville, IA). For the cell entry and disassembly
studies ﬁreﬂy luciferase mRNA was the cargo (Nickens and Hardy,
2008). Capped and polyadenylated luciferasemRNAwas generated by
in vitro transcription using SP6 polymerase and standard reaction
components (Nickens and Hardy, 2008), and was puriﬁed using an
RNeasy Mini Kit (Qiagen, Valencia, CA). Concentrations of DNA and
RNA were determined using a NanoDrop 1000 (Thermo Scientiﬁc,
Wilmington, DE).
Ross River CLPs were assembled in vitro by incubating 100 μg
capsid protein and 60 μg of nucleic acid (either DNA or RNA) at room
temperature for 10 min. CLPs were puriﬁed to remove residual capsid
protein and nucleic acid by applying the reaction mixture onto a 27%
sucrose cushion (10 ml) and centrifuging at 130,000×g for 2.5 h at
4 °C. The pellet was resuspended in PBS to give a protein concentra-
tion between 0.30 and 0.45 mg/ml as determined by a Bradford assay.
CLP puriﬁcation yield was 35–50% of starting capsid protein. CLP
formation, both before and after concentration, was veriﬁed by an
agarose gel shift assay and by TEM analysis (Mukhopadhyay et al.,
2002; Tellinghuisen et al., 1999).
Assembly of VLPs with CLPs
Thegeneral procedure to assembleVLPs is described below. The total
amount of CLPs and thenumber of cells usedwere adjusted based on the
experiment being conducted and the amount of VLPs needed for
analysis. However, the CLP:BHK cell ratio remained similar. In most
experiments, the amount of CLPs and cells used is indicated in the text. A
35 mmdish containing 2×106 BHK cellswas transfectedwith pRRV-GP.
Fifteen hours later, 3 μg of puriﬁed CLPs (approximately 2.6×1011
particles) was transfected into the pRRV-GP-transfected cells using
10 μl of Lipofectamine 2000. After 1 h, cells were washed three times
with PBS to remove residual CLPs and Lipofectamine reagent and
0.5 ml ofMEM+10% FBSwere added to the cells. After one additional
hour, the medium which contains VLPs was collected.
We tested several transfection agents for transfecting CLPs
including Lipofectamine 2000 (Invitrogen), Fugene 6 (Roche), and
PEI (Sigma). In addition we tested reagents speciﬁc for protein and
peptide transfection, including Chariot (Motif Active), and microin-
jection and syringe loading (Clarke and McNeil, 1992) of CLPs.
Lipofectamine 2000 yielded the highest efﬁciency of transfection.
Concentrating VLPs
VLPs were concentrated for western blot and TEM studies.
Medium containing VLPs was ﬁltered through a 0.45 μm syringe ﬁlter
to remove cells and cell debris. The medium was applied onto a 27%
sucrose cushion (10 ml) and centrifuged at 130,000×g for 2.5 h at
4 °C. The pellet, which contains the VLPs, was resuspended in PBS to
yield ~0.15 mg/ml of VLPs based on protein concentration.
Western blot and immunoprecipitation of VLPs
To determine the composition of VLPs, 10 μl of the resuspended
VLPs was analyzed by SDS-PAGE and probed for RRV capsid and E2
protein using polyclonal antibodies. For immunoprecipitation experi-ments, anti-capsid protein antibodies were coupled to the agarose
coupling resin columns of a ProFound Co-Immunoprecipitation
Kit (Pierce, Rockford, IL) according to the manufacturer's protocol.
As a control for non-speciﬁc binding of CLPs/protein to the agarose
beads, a sample not including antibody was also performed. Ten
microliters of the resuspended VLPs was incubated with the agarose
beads (+/−antibody) at room temperature for 2 h. Samples were
eluted from the column by SDS and analyzed by western blotting.
Transmission electron microscopy
Samples of concentrated VLPs (3–5 μl) were applied to 400-mesh
carbon-coated formvar copper grids and stained with 1% uranyl
acetate. The grids were examined on a JEOL 1010 transmission
electron microscope (Tokyo, Japan) at 80 kV. Images were recorded
using a Gatan UltraScan 4000 CCD camera (Pleasanton, CA).
Luciferase assay
VLPs containing luciferase RNA were added to cells to determine
if they were capable of entering and disassembling within a cell.
Medium containing VLPs from 6 to 35 mm dishes was collected (total
volume=3ml) and incubated with 2.4×106 BHK cells. After 12 h,
luciferase assayswere performedusing a Luciferase Assay Kit (Sigma, St.
Louis, MO) according to the manufacturer's directions. Cells were lysed
in 150 μl lysis buffer. Samples were measured using a BIO-TEK synergy
HT multimode microplate reader (BIO-TEK, Winooski, VT). Samples
weremeasured in triplicate and at least six experiments were averaged
for each sample.
The range of luminescence minimum and maximum between
experiments varied even though the relative values within an
experiment were consistent. The absolute luminescence values were
normalized for each experiment. To do so, background values deter-
mined from BHK cell lysates were subtracted from all samples. Within
each set of experiments, luminescence from particles isolated from cells
expressing RRV-GP that had been transfected with CLPs (medium
containing VLPs) was set to 1. Standard error was determined between
sets of experiments.
Treatment of VLPs and virus with neutralizing antibody
Three milliliters of medium containing VLPs was incubated with
500 μl T10C9 antibody in serum for 30 min at room temperature. The
mixture was applied to BHK cells and after 12 h luciferase activity was
determined as described above. One milliliter of wild-type Ross River
virus was incubated with 500 ml of T10C9 antibody for 30 min at
room temperature. Infectivity was determined by plaque assay.
Treatment of cells with ammonium chloride
BHK cellswere pre-treatedwith 20 mM freshly prepared ammonium
chloride for 20 min before being incubatedwith 3 ml of VLPs. After 1 h of
incubation, the medium containing the particles was removed and fresh
medium containing 20 mM ammonium chloride was added. After 12 h,
cell lysates were assayed for luciferase activity. Infectivity of Ross River
virus was determined in a similar manner. Cells were pre-treated with
20 mM NH4Cl for 20 min before being infected with Ross River virus.
After 24 h, the medium from virus-incubated cells was removed and
titered.
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